Dennis M. Lanfear
Chairman, President & CEOMr. Dennis M. Lanfear, also known as Denny, Co-founder, Chairman, Chief Executive Officer and President of Coherus Oncology, Inc. (formerly known as Coherus BioSciences, Inc.) since September 2010. Mr. Lanfear serves as the President of Lanfear Capital Advisors, LLC. He focuses on investments in therapeutic product and device companies. Mr. Lanfear founded InteKrin Therapeutics, Inc. in 2005 and has also been its Chairman of the Board since 2010. He serves as Acting President of InteKrin Therapeutics, Inc. He was President and Chief Executive Officer at InteKrin Therapeutics, Inc. from 2005 to May 2010. Mr. Lanfear was the Founder and Chief Executive Officer at Saronyx, Inc. He served as Strategic Consultant for Insmed Incorporated since October 25, 2006 until December 2007. He was a Corporate Officer and Vice President at Amgen. At Amgen, he began in 1986 as a founder of the Process Development Department. Mr. Lanfear served in various senior leadership roles at Amgen Inc., a Biopharmaceutical company from 1986 to 1999. While at Amgen, Mr. Lanfear had key leadership positions in the Process Development department, which under his management became an area of key strategic advantage for Amgen. From 1997 to 1999 Mr. Lanfear was Vice President, Market Development, focusing on long-term strategy for Epogen. Mr. Lanfear also had senior leadership roles in several product development programs including those for growth factors, somatotrophins and neurotrophins, directing efforts from preclinical to Phase III. He reviewed and wrote sections of more than 20 INDs and several BLAs. Mr. Lanfear also managed corporate partner relationships including those with SKB from 1986 to 1990 and Regeneron Pharmaceuticals from 1991 to 1999, where he had direct budgetary responsibility for the $135 million development partnership. Prior to Amgen, Mr. Lanfear was at Baxter International where he designed kilogram scale computerized protein purification systems. Mr. Lanfear served as a Director of Insmed Incorporated since December 2007. He served as a Director of Anthera Pharmaceuticals Inc. Mr. Lanfear holds B.S. degrees in Chemical Engineering and Biochemistry from Michigan State University and an M.B.A. from the Anderson School of Management at the University of California, Los Angeles.
Positions
- Company NameCoherus Oncology, Inc.Stock CodeCHRSPositionChairman, President & CEOColleagues
- BJBryan J. McMichaelChief Financial Officer
- CGCarrie GrahamVice President of Investor Relations & Advocacy
- ARAndy RittenbergChief Legal Officer
- RSRebecca SunshineChief Human Resources Officer
- TMTheresa M. LavalleeChief Development Officer & Chairman of Scientific Advisory Board
- AJAli J. SatvatIndependent Director
- CWCharles W. NewtonIndependent Director
- RARita A. KarachunIndependent Director
